	US 12,076,307 B2
	Compositions for prevention or treatment of acute radiation syndrome and other radiation exposure
Ki Young Sohn, Seoul (KR); and Sun Young Yoon, Seoul (KR)
Assigned to Enzychem Lifesciences Corporation, Seoul (KR)
Filed by Enzychem Lifesciences Corporation, Englewood Cliffs, NJ (US)
Filed on May 30, 2020, as Appl. No. 16/888,716.
Application 16/888,716 is a continuation in part of application No. PCT/IB2018/059538, filed on Nov. 30, 2018.
Claims priority of provisional application 62/691,604, filed on Jun. 28, 2018.
Claims priority of application No. 10-2017-0162404 (KR), filed on Nov. 30, 2017.
Prior Publication US 2020/0397737 A1, Dec. 24, 2020
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/231 (2006.01); A61K 38/19 (2006.01); A61K 45/06 (2006.01); A61P 39/00 (2006.01); A61P 43/00 (2006.01)

CPC A61K 31/231 (2013.01) [A61K 38/193 (2013.01); A61K 45/06 (2013.01); A61P 39/00 (2018.01); A61P 43/00 (2018.01)]

18 Claims

1. A method for treating acute radiation syndrome in a subject, comprising:

administering to the subject a therapeutically effective amount of 1-palmitoyl-2-linoleoyl-3-acetylglycerol (PLAG).